Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 230 member A (FAM230A) is a gene that encodes a long non-coding RNA (lncRNA), and is also known by the alias DGCR15[2]. This RNA gene is classified within the lncRNA class and does not encode a protein product. Diseases associated with FAM230A include retinitis pigmentosa 43 and distal chromosome 22q11.2 deletion syndrome. Specific biological function for the FAM230A transcript remains undefined, and there is currently no evidence supporting its use as a direct drug target, biomarker, or diagnostic tool[2]. No information identifies this molecule as a therapeutic target, receptor, enzyme, transporter, or transcription factor. The literature and gene databases classify it as a non-coding RNA gene, likely having regulatory roles, but its precise biological function and mechanisms of action have not been characterized[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 230 member A (FAM230A).